KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹15 Cr | ₹10 Cr | ₹7.37 Cr | ₹3.67 Cr | ₹0.84 Cr |
What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹7.37 Cr |
Mar2021 | ₹3.67 Cr |
Mar2020 | ₹0.84 Cr |
How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | 39.75 | |
Mar2023 | ₹10 Cr | 41.82 | |
Mar2022 | ₹7.37 Cr | 100.68 | |
Mar2021 | ₹3.67 Cr | 335.99 | |
Mar2020 | ₹0.84 Cr | - |
Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹549.3 Cr | -5.2% | -4.1% | -1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,725.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,525.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
CIPLA | ₹123,206.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,519.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,927.5 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | -5.2% |
-4.1% |
-1% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses